Endocrine, Nutritional, and Metabolic Diseases
(ICD-10-CM Chapter 4, Codes E00-E89)
Learning Objectives
2. Identify pertinent anatomy and physiology of the endocrine, nutritional, and metabolic diseases
3. Identify endocrine, nutritional, and metabolic diseases
5. Identify common treatments, medications, laboratory values, and diagnostic tests
6. Explain the importance of documentation in relation to MS-DRGs for reimbursement
Abbreviations/Acronyms
AIDS acquired immunodeficiency syndrome
BMI body mass index
CDC Centers for Disease Control and Prevention
ICD-9-CM International Classification of Diseases, 9th Revision, Clinical Modification
ICD-10-CM International Classification of Diseases, 10th Revision, Clinical Modification
ICD-10-PCS International Classification of Diseases, 10th Revision, Procedure Coding System
IDDM insulin-dependent diabetes mellitus
IV intravenous
MEN multiple endocrine neoplasia
MS-DRG Medicare Severity diagnosis-related group
NIDDM non–insulin-dependent diabetes mellitus
OIG Office of the Inspector General
PKU phenylketonuria
PVD peripheral vascular disease
SIADH syndrome of inappropriate antidiuretic hormone secretion
TPN total parenteral nutrition
TSH thyroid-stimulating hormone
VBG vertical banded gastroplasty
ICD-10-CM Official Guidelines for Coding and Reporting
Please refer to the companion Evolve website for the most current guidelines.
4. Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89)
a. Diabetes mellitus
The diabetes mellitus codes are combination codes that include the type of diabetes mellitus, the body system affected, and the complications affecting that body system. As many codes within a particular category as are necessary to describe all of the complications of the disease may be used. They should be sequenced based on the reason for a particular encounter. Assign as many codes from categories E08-E13 as needed to identify all of the associated conditions that the patient has.
1) Type of diabetes
The age of a patient is not the sole determining factor, though most type 1 diabetics develop the condition before reaching puberty. For this reason type 1 diabetes mellitus is also referred to as juvenile diabetes.
2) Type of diabetes mellitus not documented
If the type of diabetes mellitus is not documented in the medical record the default is E11.-, Type 2 diabetes mellitus.
3) Diabetes mellitus and the use of insulin
If the documentation in a medical record does not indicate the type of diabetes but does indicate that the patient uses insulin, code E11, Type 2 diabetes mellitus, should be assigned. Code Z79.4, Long-term (current) use of insulin, should also be assigned to indicate that the patient uses insulin. Code Z79.4 should not be assigned if insulin is given temporarily to bring a type 2 patient’s blood sugar under control during an encounter.
4) Diabetes mellitus in pregnancy and gestational diabetes
See Section I.C.15. Diabetes mellitus in pregnancy.
See Section I.C.15. Gestational (pregnancy induced) diabetes
5) Complications due to insulin pump malfunction
(a) Underdose of insulin due to insulin pump failure
An underdose of insulin due to an insulin pump failure should be assigned to a code from subcategory T85.6, Mechanical complication of other specified internal and external prosthetic devices, implants and grafts, that specifies the type of pump malfunction, as the principal or first-listed code, followed by code T38.3×6-, Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs. Additional codes for the type of diabetes mellitus and any associated complications due to the underdosing should also be assigned.
(b) Overdose of insulin due to insulin pump failure
The principal or first-listed code for an encounter due to an insulin pump malfunction resulting in an overdose of insulin, should also be T85.6-, Mechanical complication of other specified internal and external prosthetic devices, implants and grafts, followed by code T38.3×1-, Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional).
6) Secondary diabetes mellitus
Codes under categories E08, Diabetes mellitus due to underlying condition, and E09, Drug or chemical induced diabetes mellitus, and E13, Other specified diabetes mellitus, identify complications/manifestations associated with secondary diabetes mellitus. Secondary diabetes is always caused by another condition or event (e.g., cystic fibrosis, malignant neoplasm of pancreas, pancreatectomy, adverse effect of drug, or poisoning).
(a) Secondary diabetes mellitus and the use of insulin
For patients who routinely use insulin, code Z79.4, Long-term (current) use of insulin, should also be assigned. Code Z79.4 should not be assigned if insulin is given temporarily to bring a patient’s blood sugar under control during an encounter.
(b) Assigning and sequencing secondary diabetes codes and its causes
The sequencing of the secondary diabetes codes in relationship to codes for the cause of the diabetes is based on the Tabular List instructions for categories E08, E09 and E13.
(i) Secondary diabetes mellitus due to pancreatectomy
For postpancreatectomy diabetes mellitus (lack of insulin due to the surgical removal of all or part of the pancreas), assign code E89.1, Postprocedural hypoinsulinemia. Assign a code from category E13 and a code from subcategory 290.41-, Acquired absence of pancreas, as additional codes.
(ii) Secondary diabetes due to drugs
Secondary diabetes may be caused by an adverse effect of correctly administered medications, poisoning or sequela of poisoning.See section I.C.19.e for coding of adverse effects and poisoning, and section I.C.20 for external cause code reporting.
Apply the General Coding Guidelines as found in Chapter 5 and the Procedural Coding Guidelines as found in Chapters 6 and 7.
Anatomy and Physiology
The endocrine system (Figure 12-1) works with the nervous system to maintain body functions and homeostasis, and to respond to stress. The endocrine system is composed of many glands that are located throughout the body. These glands secrete hormones that can regulate bodily functions such as urinary output, cellular metabolic rate, growth, and development.
Major endocrine glands include the following:
See Table 12-1 for a listing of the glands, corresponding hormones, and expected hormonal response.
TABLE 12-1
MAJOR ENDOCRINE GLAND SECRETIONS AND FUNCTIONS1
Endocrine Gland | Hormone | Target Action |
Anterior pituitary | Growth hormone (GH) | Promotes bone and tissue growth |
Thyrotropin (thyroid-stimulating hormone [TSH]) | Stimulates thyroid gland and production of thyroxine | |
Corticotropin (adrenocorticotropic hormone [ACTH]) | Stimulates adrenal cortex to produce glucocorticoids | |
Gonadotropin | Initiates growth of eggs in ovaries; stimulates spermatogenesis in testes | |
Follicle-stimulating hormone (FSH) | ||
Luteinizing hormone (LH) | Causes ovulation; stimulates ovaries to produce estrogen and progesterone; stimulates testosterone production | |
Prolactin | Stimulates breast development and formation of milk during pregnancy and after delivery | |
Melanocyte-stimulating hormone (MSH) | Regulates skin pigmentation | |
Posterior pituitary | Vasopressin (antidiuretic hormone [ADH]) | Stimulates water resorption by renal tubules; has antidiuretic effect |
Oxytocin | Stimulates uterine contractions; stimulates ejection of milk in mammary glands; causes ejection of secretions in male prostate gland | |
Thyroid | Thyroxine (T4) and triiodothyronine (T3)—thyroid hormone (TH) | Regulates rate of cellular metabolism (catabolic phase) |
Calcitonin | Promotes retention of calcium and phosphorus in bone; opposes effect of parathyroid hormone | |
Parathyroid | Parathyroid hormone (parathormone, PTH) | Regulates metabolism of calcium; elevates serum calcium levels by drawing calcium from bones |
Adrenal cortex | Mineralocorticoids (MCs), primarily aldosterone | Promote retention of sodium by kidneys; regulate electrolyte and fluid homeostasis |
Glucocorticoids (GCs): cortisol, corticosterone, cortisone | Regulate metabolism of carbohydrates, proteins, and fats in cells | |
Gonadocorticoids: androgens, estrogens, progestins | Govern secondary sex characteristics and masculinization | |
Adrenal medulla | Catecholamines: epinephrine and norepinephrine | Produce quick-acting “fight or flight” response during stress; increase blood pressure, heart rate, and blood glucose level; dilate bronchioles |
Pancreas | Insulin | Regulates metabolism of glucose in body cells; maintains proper blood glucose level |
Glucagon | Increases concentration of glucose in blood by causing conversion of glycogen to glucose | |
Ovaries | Estrogens | Cause development of female secondary sex characteristics |
Progesterone | Prepares and maintains endometrium for implantation and pregnancy | |
Testes | Testosterone | Stimulates and promotes growth of male secondary sex characteristics and is essential for erections |
Thymus | Thymosin | Promotes development of immune cells (gland atrophies during adulthood) |
Pineal gland | Melatonin | Regulates daily patterns of sleep and wakefulness; inhibits hormones that affect ovaries; other functions unknown |
Endocrine diseases may result from an abnormal decrease or increase in hormone production. Changes in the size of a gland can alter hormone production. If the gland becomes larger, this is called hyperplasia and/or hypertrophy. If the gland becomes smaller, this is called hypoplasia and/or atrophy. Infection, inflammation, radiation, trauma, and surgical procedures can produce changes in the gland and hormonal dysfunction.
Some common mental and physical symptoms include the following:
Disease Conditions
Diseases of the endocrine system and nutritional and metabolic disorders (E00 to E89), covered in Chapter 4 of the ICD-10-CM code book, are divided into the following categories:
CATEGORY | SECTION titles |
E00-E07 | Disorders of the thyroid gland |
E08-E13 | Diabetes mellitus |
E15-E16 | Other disorders of glucose regulation and pancreatic internal secretion |
E20-E35 | Disorders of other endocrine glands |
E36 | Intraoperative complications of endocrine system |
E40-E46 | Malnutrition |
E50-E64 | Other nutritional deficiencies |
E65-E68 | Overweight, obesity, and other hyperalimentation |
E70-E88 | Metabolic disorders |
E89 | Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified |
Diabetes mellitus is a common disease condition and should be coded according to the specific type. The diabetes codes are combination codes that identify the type of diabetes, the body system that is affected, and the manifestation.
In lCD-10-CM there are five category codes for the types of diabetes mellitus:
Disorders of Thyroid Gland (E00-E07)
Goiter
Goiter is an enlargement of the thyroid gland (Figure 12-2). This enlargement may be uniform throughout the gland or diffuse. Enlargement may also occur in the form of nodules or nodular goiter. A goiter can cause difficulties in swallowing and/or breathing and may or may not be associated with hormonal disturbances. The most common cause is lack of iodine in the diet. Goiters due to iodine deficiency are rare in the United States since the introduction of iodized salt.
Hypothyroidism
Hypothyroidism is diminished production of thyroid hormone, manifested by low metabolic rate, tendency toward weight gain, somnolence, and sometimes myxedema. Myxedema is a skin and tissue disorder that is usually due to severe, prolonged hypothyroidism (Figure 12-3). Symptoms include dull, puffy, yellowed skin; coarse, sparse hair; periorbital edema; and prominent tongue.
Hashimoto’s disease is an inflammation of the thyroid gland that often results in hypothyroidism. It is most common in women and individuals who have a family history of thyroid disease. Onset of Hashimoto’s is slow, and it may not be detected for years. The most common signs and symptoms of Hashimoto’s disease include the following:
Hyperthyroidism/Graves’ Disease
Hyperthyroidism (Figure 12-4) is an abnormality of the thyroid gland in which secretion of thyroid hormone is usually increased and is no longer under the regulatory control of hypothalamic-pituitary centers.
Graves’ disease, the most common form of hyperthyroidism, occurs as the result of an autoimmune response that attacks the thyroid gland, resulting in overproduction of the thyroid hormone thyroxine. Graves’ disease is most common among women between 20 and 40 years of age. The most common signs and symptoms include the following:
Graves’ ophthalmopathy is also fairly common and may result in exophthalmos, or bulging eyes (Figure 12-5). A complication of hyperthyroidism is thyrotoxic crisis or storm. This is a sudden intensification of symptoms combined with fever, rapid pulse, and delirium. Medical attention is required when a crisis episode occurs.
Common causes of a thyrotoxic storm or crisis include a medical illness or infection. Other causes include the following:
Exercise 12-1
Assign codes to the following conditions.
1. Thyroid nodule | _______________ |
2. Sick-euthyroid syndrome | _______________ |
3. Graves’ disease with thyrotoxic crisis | _______________ |
4. Hashimoto’s disease | _______________ |
5. Congenital hypothyroidism | _______________ |
Diabetes Mellitus (E08-E13) and Other Disorders of Glucose Regulation and Pancreatic Internal Secretion (E15-E16)
Diabetes Mellitus
Diabetes mellitus is a chronic syndrome of impaired carbohydrate, protein, and fat metabolism caused by insufficient production of insulin by the pancreas or faulty utilization of insulin by the cells. The coding of diabetes mellitus (DM) may be complicated because various manifestations are associated with the disease.
There are two major types of diabetes mellitus: type 1 and type 2. These types vary in origin, pathology, genetics, age of onset, and treatment (Table 12-2). Patients with type 1 diabetes are insulin dependent; this condition usually develops early in life. The pancreas produces insulin in very small amounts or not at all. Type 2 diabetes usually is of adult onset. The pancreas continues to produce insulin, but it is not properly metabolized. Occasionally, patients with type 2 diabetes must be treated with insulin so that acceptable glucose levels are maintained; the fact that they are taking insulin does not mean that they are dependent on insulin, or that they have type 1 diabetes. Type 2 diabetes is much more common than type 1; 90% to 95% of diabetic patients have type 2 diabetes. Type 2 diabetes in adolescents and children is a relatively new phenomenon, and statistics are still being collected. Sometimes, diabetes is documented as insulin-dependent diabetes mellitus (IDDM) or non–insulin-dependent diabetes mellitus (NIDDM). Documentation of insulin dependence does not determine the type of diabetes, because a patient with type 2 diabetes may be on insulin. If only IDDM is documented, and type 1 or type 2 is not specified, according to coding guidelines, the default is type 2 diabetes.
TABLE 12-2
COMPARISON OF TYPE 1 AND TYPE 2 DIABETES MELLITUS2
Type 1 | Type 2 | |
Features | Usually occurs before age 30 | Usually occurs after age 30 |
Abrupt, rapid onset | Gradual onset; asymptomatic | |
Little or no insulin production | Insulin usually present | |
Thin or normal body weight at onset | 85% are obese | |
Ketoacidosis often occurs | Ketoacidosis seldom occurs | |
Symptoms | Polyuria (glycosuria promotes loss of water) | Polyuria sometimes seen |
Polydipsia (dehydration causes thirst) | Polydipsia sometimes seen | |
Polyphagia (tissue breakdown causes hunger) | Polyphagia sometimes seen | |
Treatment | Insulin | Diet; oral hypoglycemics or insulin |